I

InVitro Cell Research, LLC Tech Stack

Regenerative medicine research focused on slowing and reversing biological aging

Biotechnology Research Englewood, New Jersey 11–50 employees Founded 2015 Privately Held

InVitro Cell Research runs a focused regenerative medicine lab with ~20 active research roles, split heavily toward wet-lab science (molecular screening, biomarker discovery, multi-omic integration) and minimal data infrastructure (one data hire). The tech stack is biology-first—Tecan, qPCR, ddPCR, ELISPOT—paired with R, Python, and XGBoost for analysis. The senior/principal seniority skew (10 of 12 research hires at mid-level or above) and concentrated project list (tinnitus intervention, neuroregeneration, senolytics, atherosclerosis prevention) indicate a small team structured around deep specialization rather than scale.

Tech Stack 13 technologies

Core StackPython GitHub Linux Tecan R ddPCR Microsoft Access iOS XGBoost SVM ELISPOT qPCR PubMed

What InVitro Cell Research, LLC Is Building

◆Challenges

Tinnitus and age-related hearing dysfunction
Managing large amounts of knowledge
Synthesizing biomedical literature
Developing interventions for tinnitus
Improving tinnitus management strategies

▲Active Projects

Molecular screening assays
Tinnitus intervention development
Snp functional impact research
Neurodegeneration/neuroregeneration program
Personalized biomarker discovery for hard-to-diagnose diseases
Multi-omic integration for personalized medicine
Tinnitus intervention research
Tinnitus management strategy evaluation
Therapeutic target identification
Early warning system development

Hiring Activity

Accelerating20 roles · 10 in 30d

Department

Research

19

Data

1

Seniority

Mid

8

Senior

6

Principal

4

Junior

2

Company intelligence

Find more companies like InVitro Cell Research, LLC by tech stack, pain points and active projects

Get started free

About InVitro Cell Research, LLC

InVitro Cell Research is a privately held regenerative medicine company founded in 2015, headquartered in Englewood, New Jersey. The company conducts basic and translational research on interventions to slow and reverse aging and prevent age-related diseases, with active programs in neuroregeneration, immune regeneration, senolytic compounds, and early disease detection. They operate as a small collaborative research group, emphasizing direct investment in scientist capability and hands-on lab work over organizational overhead. Current hiring is concentrated in research roles across molecular biology, biomarker discovery, and personalized medicine platforms.

HeadquartersEnglewood, New Jersey

Company Size11–50 employees

Founded2015

Hiring MarketsUnited States

Frequently Asked Questions

What does InVitro Cell Research work on?

Research on regenerative medicine and biological aging interventions, including programs in neuroregeneration, tinnitus intervention, immune regeneration, senolytics, and atherosclerosis prevention. Active projects span molecular screening, personalized biomarker discovery, and multi-omic integration for personalized medicine.

What is InVitro Cell Research's tech stack?

Biology-focused instrumentation (Tecan, qPCR, ddPCR, ELISPOT) combined with R, Python, XGBoost, GitHub, and Linux for data analysis. Microsoft Access for database management and PubMed for literature access.